NASDAQ:MNOV
MediciNova Stock News
$1.42
-0.0100 (-0.699%)
At Close: May 17, 2024
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 27)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
Here's Why MediciNova Is Soaring Today
05:09pm, Monday, 27'th Jul 2020
Shares of MediciNova (NASDAQ: MNOV) jumped over 65% today after the company announced a collaboration with BioComo and Mie University to develop a vaccine against SARS-CoV-2. The technology platform
MediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan
10:30am, Monday, 27'th Jul 2020
LA JOLLA, Calif., July 27, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Co
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.43%
12:00am, Monday, 27'th Jul 2020
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.43%
MediciNova to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit
10:30am, Monday, 20'th Jul 2020
LA JOLLA, Calif., July 20, 2020 -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock.
Acute Respiratory Distress Syndrome (ARDS) - Market Insights, Epidemiology and Forecast to 2030 - ResearchAndMarkets.com
12:00am, Tuesday, 14'th Jul 2020
The
MNOV: FDA Gives OK to Initiate Clinical Trial of MN-166 to Prevent ARDS in COVID-19 Patients…
09:47am, Thursday, 02'nd Jul 2020
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update FDA Approves Clinical Plan for MN-166 to Prevent ARDS Caused by COVID-19 On July 1, 2020, MediciNova, Inc. (NASDAQ:MN
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the Investigational
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
12:28pm, Friday, 26'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25) * Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) *
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced positive preclinical find
LA JOLLA, Calif., June 25, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and...
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) * ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) * Accel
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received
6 Stocks That Could Jump Higher
12:00am, Tuesday, 16'th Jun 2020
Stocks Analysis by Harry Boxer covering: Celsion Corp, Celldex Therapeutics Inc, Digital Ally Inc, Dynavax Technologies Corporation. Read Harry Boxer's latest article on Investing.com
89bio (NASDAQ:ETNB) vs. MediciNova (NASDAQ:MNOV) Financial Contrast
03:26am, Sunday, 14'th Jun 2020
89bio (NASDAQ:ETNB) and MediciNova (NASDAQ:MNOV) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendatio
